Gerald L. “Jerry” Feldman, M’84, PhD’ 82
The American College of Medical Genetics and Genomics (ACMG) has named Gerald L. “Jerry” Feldman, M’84, PhD’ 82, president of the national organization for clinical and laboratory genetics professionals. During his two-year term, Feldman plans to embrace new technologies and treatments and improve organizational structure as the field of medical genetics continues to expand.
“Dr. Feldman has a long history with ACMG, and through his extensive committee work, he’s taken an active role in steering us to where we are today,” said Michael S. Watson, executive director of the ACMG, in a news release from his organization. “His institutional knowledge and experience working across the full spectrum of clinical genetics services and education will help our organization going forward, in an era when genomic information promises to play a bigger role in medicine than it ever has before.”
Feldman spent two years as president-elect of the ACMG, serving on various committees and taskforces while preparing for his role as president of the organization. Feldman also works as a professor of molecular genetics, pathology and pediatrics at Wayne State University in Detroit, Mich., where he directs the medical genetics residency and fellowship programs and serves as medical director of the Genetic Counseling Graduate Program.
His principal research focuses on diagnosing and managing patients with genetic disorders. He is co-investigator for the NIH program Inborn Errors of Metabolism Collaborative, which collects data and studies best practices in service of children with rare genetic disorders which prevent them from metabolizing certain fats, proteins and sugars.
Feldman also serves in several clinical roles, among them program director and lead investigator of the Newborn Screening Management Program at the Children’s Hospital of Michigan and director of clinical genetic services at Wayne State. Feldman’s combination of experience in clinical care, education and research makes him uniquely qualified to represent the diverse body of ACMG members.
“The era of the genetic and genomic revolution is here,” said Feldman. “New technologies, new treatments and identification of new genetic disorders will improve patient care in ways we could not have even envisioned a few years ago. I look forward to serving as president of the organization that is leading these efforts.”
The ACMG has more than 1,750 members, among them biochemical, clinical, medical and molecular geneticists, genetic counselors and other health care professionals. As the only nationally recognized medical organization dedicated to improving health through the practice of medical genetics and genomics, the organization seeks to promote medical genetics education, research and access while advocating for its members and other providers of medical genetics services and their patients.
By Jack Carmichael